Showing 1-10 of about 636 articles.
Inspirata, Inc.
Tampa, Florida, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that the United States Patent and Trademark Office (USPTO) has issued...
KULR Technology Group, Inc.
SAN DIEGO, Jan. 07, 2021 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (OTCQB: KULR) (the “Company” or “KULR”), a leading developer of battery safety and thermal management technologies, today...
KULR Technology Group, Inc.
$8 million capital raise supports growth strategies and fulfilling projects yet to be announcedFinancing is expected to advance KULR’s up listing process to a national securities exchange Management...
Monopar Therapeutics Inc.
-Issued patent expands and strengthens Monopar’s existing camsirubicin IP portfolio-Phase 2 initiation for camsirubicin in advanced soft tissue sarcoma remains on track for early 2021 WILMETTE,...
Voip-Pal.Com Inc.
CEO Emil Malak authored an op-ed published on ceocfomagazine.com regarding the departure of Directors Dr. Colin Ticker and Professor Edwin Candy BELLEVUE, Wash., Dec. 21, 2020 (GLOBE NEWSWIRE) --...
KULR Technology Group, Inc.
SAN DIEGO, Dec. 10, 2020 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (OTCQB: KULR) (the “Company” or “KULR”), a leading developer of next-generation thermal management technologies, today...
SmileDirectClub
NASHVILLE, Tenn., Dec. 08, 2020 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the oral care company with the first telehealth platform for teeth straightening, today announced it has...
TeraRecon, Inc
DURHAM, N.C., Nov. 29, 2020 (GLOBE NEWSWIRE) -- TeraRecon, the leading provider of AI-driven advanced visualization solutions, has been awarded an expansion of their patent-protected AI...
C-Bond Systems
Patent titled “Composition and Method for Multipurpose Emulsion that Strengthens Glass and Modifies Glass Surface” filed to protect the C-Bond NanoShield technology, created to address the $5 billion...
Monopar Therapeutics Inc.
WILMETTE, Ill., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics...
Showing 1-10 of about 636 articles.
